Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Forum Pharmaceuticals Inc.

www.forumpharma.com

Latest From Procter & Gamble Pharmaceuticals Inc.

FDA Adds New Co-Primary Endpoint For Female Sexual Desire Drugs

Draft guidance says 'associated distress' may replace number of satisfying sexual events as a co-primary efficacy endpoint.

Clinical Trials Drug Approval Standards

Timing Better For Sprout’s Latest Shot At First Female Sex Desire Drug

Sprout’s flibanserin resubmission should have an easier time at FDA, as experts backed key aspects of trial design used in flibanserin studies and patients sought treatment options at last year’s workshop on female sexual dysfunction.

BioPharmaceutical Clinical Trials

Timing Better For Sprout’s Latest Shot At First Female Sex Desire Drug

Sprout’s flibanserin resubmission should have an easier time at FDA, as experts backed key aspects of trial design used in flibanserin studies and patients sought treatment options at last year’s workshop on female sexual dysfunction.

Clinical Trials Regulation

A New Dawn For Female Sex Dysfunction Drugs? FDA Meeting Cheers Sponsors

Experts convened by FDA to discuss female sexual dysfunction disorders, including problems with desire and arousal, settle on endpoints contrary to new DSM, but are in line with trials of Sprout’s flibanserin, the leading drug in development.

BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • EnVivo Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Forum Pharmaceuticals Inc.
  • Senior Management
  • Dana C Hilt, MD, SVP, Clin. Dev. & CMO
    Christopher L Burnley, SVP & CBO
  • Contact Info
  • Forum Pharmaceuticals Inc.
    Phone: (617) 225-4250
    500 Arsenal St.
    Watertown, MA 02472
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register